EXCLI J EXCLI Journal 1611-2156 Leibniz Research Centre for Working Environment and Human Factors 2015-763 10.17179/excli2015-763 Doc1264 Editorial material Highlight report: New methods for quantification of bile canalicular dynamics Ghallab Ahmed * 1 Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt *To whom correspondence should be addressed: Ahmed Ghallab, Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt, E-mail: ghallab@vet.svu.edu.eg 21 12 2015 2015 14 1264 1266 09 12 2015 15 12 2015 Copyright © 2015 Ghallab 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.

This article is available from http://www.excli.de/vol14/Ghallab_21122015_Highlight_report_proof.pdf

Cholestasis represents one of the main causes of hepatotoxicity. It is defined by impaired bile flux from hepatocytes to the gall bladder. Cholestasis can be caused by inhibition of the transport of bile acids from hepatocytes into bile canaliculi. Moreover, physical obstructions or impaired flux in the canaliculi or bile ducts may be responsible. Since decades cultivated hepatocytes have been used to study the cholestatic properties of chemicals (Dunn et al., 1989[7]). Tests in this field are based on the release and subsequent analysis of the canalicular content (Liu et al., 1999[22][23][24]; Bi et al., 2006[1]; Kostrubsky et al., 2003[20]). However, relatively little is known whether compromised bile canalicular dynamics, the rhythmic contractions of bile canaliculi, play a role in cholestasis. Therefore, Raymond Reif and colleagues have established an in vitro system that based on time-lapse microscopy allows the quantification of bile canalicular dynamics (Reif et al., 2015[29]). This technique measures the repetitive swelling and collapsing of bile canaliculi. This period typically lasts for approximately 30 h after plating of mouse hepatocytes. Afterwards, the luminal diameter of the bile canaliculi becomes narrower and more constant (Reif et al., 2015[29]). In this state it resembles morphology and dynamics of bile canalicular structures in vivo (Reif et al., 2015[29]). An interesting observation is that exposure to dexamethasone/insulin increased both, the amplitude of the initial contractions during the first 30 h and also the diameter of the mature canaliculi between 30 and 75 h after plating of the hepatocytes. In conclusion, Reif and colleagues have established a relatively easy to handle technique to quantify bile canalicular dynamics and they have shown that this parameter can be influenced by chemicals. However, whether compromised bile canalicular dynamics play a key role in pathogenesis of cholestasis still remains to be studied in future.

Prediction of hepatotoxicity represents a cutting edge topic in toxicology (Ghallab et al., 2015[12]; Godoy et al., 2009[13], 2013[14], 2015[15]; Kim et al., 2015[19]; Hengstler et al., 2014[18]; Drasdo et al., 2014[4][5]; Frey et al., 2014[8]; Mazzanti et al., 2015[25]; Tolosa et al., 2015[35]; Chen et al., 2014[3]; Vitins et al., 2014[37]; Liu et al., 2014[21]). An intensively studied field are in vitro systems for hepatotoxicity, because they may improve the throughput and avoid difficulties due to interspecies extrapolation, because human cells can be used (Schyschka et al., 2013[31]; Messner et al., 2013[26]; Wobus and Löser, 2011[38]; O'Brien et al., 2006[27]). However, because of their limitations, in vitro systems have also been critically discussed (Reif, 2014[28]; Ghallab, 2013[10], 2014[11][9]; Stöber, 2014[34]; Hammad, 2013[17]). Many in vitro systems in the field of hepatotoxicity focus on alterations in gene expression caused by the test compounds (Shinde et al., 2015[32][33]; Campos et al., 2014[2]; Rodrigues et al., 2013[30]; Driessen et al., 2013[6]; Tolosa et al., 2013[36]; Grinberg et al., 2014[16]). Other endpoints, such as bile canalicular dynamics have been studied only rarely, possibly due to technical challenges. Therefore, it is fortunate that techniques for analysis of bile canalicular dynamics are now available. However, if - and if yes to which degree - compromised motility of bile canaliculi contributes to hepatotoxicity still has to be elucidated.

Bi YA Kazolias D Duignan DB Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport Drug Metab Dispos 2006 34 1658 1665 Campos G Schmidt-Heck W Ghallab A Rochlitz K Pütter L Medinas DB The transcription factor CHOP, a central component of the transcriptional regulatory network induced upon CCl4 intoxication in mouse liver, is not a critical mediator of hepatotoxicity Arch Toxicol 2014 88 1267 1280 Chen M Tung CW Shi Q Guo L Shi L Fang H A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model Arch Toxicol 2014 88 1439 1449 Drasdo D Bode J Dahmen U Dirsch O Dooley S Gebhardt R The virtual liver: state of the art and future perspectives Arch Toxicol 2014 88 2071 2075 Drasdo D Hoehme S Hengstler JG How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis J Hepatol 2014 61 951 956 Driessen M Kienhuis AS Pennings JL Pronk TE van de Brandhof EJ Roodbergen M Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling Arch Toxicol 2013 87 807 823 Dunn JC Yarmush ML Koebe HG Tompkins RG Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration FASEB J 1989 3 174 177 Frey O Misun PM Fluri DA Hengstler JG Hierlemann A Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis Nat Commun 2014 5 4250 Ghallab A Human non-parenchymal liver cells for co-cultivation systems EXCLI J 2014 13 1295 1296 Ghallab A In vitro test systems and their limitations EXCLI J 2013 12 1024 1026 Ghallab A The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI) EXCLI J 2014 13 1286 1288 Ghallab A Cellière G Henkel SG Driesch D Hoehme S Hofmann U Model guided identification and therapeutic implications of an ammonia sink mechanism J Hepatol 2015 [Epub ahead of print] 10.1016/j.jhep.2015.11.018. pii: S0168-8278(15)00776-X Available from: http://dx.doi.org/10.1016/j.jhep.2015.11.018 Godoy P Hengstler JG Ilkavets I Meyer C Bachmann A Müller A Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis Hepatology 2009 49 2031 2043 Godoy P Hewitt NJ Albrecht U Andersen ME Ansari N Bhattacharya S Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Arch Toxicol 2013 87 1315 1530 Godoy P Schmidt-Heck W Natarajan K Lucendo-Villarin B Szkolnicka D Asplund A Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells J Hepatol 2015 63 934 942 Grinberg M Stöber RM Edlund K Rempel E Godoy P Reif R Toxicogenomics directory of chemically exposed human hepatocytes Arch Toxicol 2014 88 2261 2287 Hammad S Advances in 2D and 3D in vitro systems for hepatotoxicity testing EXCLI J 2013 12 993 996 Hengstler JG Marchan R Bolt HM Standard compounds for establishment of in vitro test systems Arch Toxicol 2014 88 2083 2084 Kim JY Fluri DA Marchan R Boonen K Mohanty S Singh P 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis J Biotechnol 2015 205 24 35 Kostrubsky VE Strom SC Hanson J Urda E Rose K Burliegh J Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats Toxicol Sci 2003 76 220 228 Liu A Krausz KW Fang ZZ Brocker C Qu A Gonzalez FJ Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity Arch Toxicol 2014 88 983 996 Liu X Chism JP LeCluyse EL Brouwer KR Brouwer KL Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats Drug Metab Dispos 1999 27 637 644 Liu X LeCluyse EL Brouwer KR Gan LS Lemasters JJ Stieger B Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration Am J Physiol 1999 277 G12 G21 Liu X LeCluyse EL Brouwer KR Lightfoot RM Lee JI Brouwer KL Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes J Pharmacol Exp Ther 1999 289 1592 1599 Mazzanti G Di Sotto A Vitalone A Hepatotoxicity of green tea: an update Arch Toxicol 2015 89 1175 1191 Messner S Agarkova I Moritz W Kelm JM Multi-cell type human liver microtissues for hepatotoxicity testing Arch Toxicol 2013 87 209 213 O'Brien PJ Irwin W Diaz D Howard-Cofield E Krejsa CM Slaughter MR High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening Arch Toxicol 2006 80 580 604 Reif R The body-on-a-chip concept: possibilities and limitations EXCLI J 2014 13 1283 1285 Reif R Karlsson J Günther G Beattie L Wrangborg D Hammad S Bile canalicular dynamics in hepatocyte sandwich cultures Arch Toxicol 2015 89 1861 1870 Rodrigues AV Rollison HE Martin S Sarda S Schulz-Utermoehl T Stahl S In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid Arch Toxicol 2013 87 1569 1579 Schyschka L Sánchez JJ Wang Z Burkhardt B Müller-Vieira U Zeilinger K Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity Arch Toxicol 2013 87 1581 1593 Shinde V Klima S Sureshkumar PS Meganathan K Jagtap S Rempel E Human pluripotent stem cell based developmental toxicity assays for chemical safety screening and systems biology data generation J Vis Exp 2015 17 100 e52333 Shinde V Stöber R Nemade H Sotiriadou I Hescheler J Hengstler J Transcriptomics of hepatocytes treated with toxicants for investigating molecular mechanisms underlying hepatotoxicity Methods Mol Biol 2015 1250 225 240 Stöber R Transcriptome based differentiation of harmless, teratogenetic and cytotoxic concentration ranges of valproic acid EXCLI J 2014 13 1281 1282 Tolosa L Gómez-Lechón MJ Donato MT High-content screening technology for studying drug-induced hepatotoxicity in cell models Arch Toxicol 2015 89 1007 1022 Tolosa L Gómez-Lechón MJ Pérez-Cataldo G Castell JV Donato MT HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved Arch Toxicol 2013 87 1115 1127 Vitins AP Kienhuis AS Speksnijder EN Roodbergen M Luijten M van der Ven LT Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models Arch Toxicol 2014 88 1573 1588 Wobus AM Löser P Present state and future perspectives of using pluripotent stem cells in toxicology research Arch Toxicol 2011 85 79 117